Skip to main content
. 2022 Oct 19;14(20):5128. doi: 10.3390/cancers14205128

Figure 5.

Figure 5

Overall survival (OS) of MB_G3 versus MB_G4 of 21 patients with recurrent non-WNT/non-SHH medulloblastoma for which molecular group was known.